Clariant AG · SIX:CLN

Clariant — 9M 2001 Earnings Presentation

22 slides from Clariant's earnings presentation, Oct 17, 2001

  1. Slide 1: Nine months 2001: Conference call

    Nine months 2001: Conference call Dr. Reinhard Handte, Chief Executive Officer François Note, Chief Financial Officer 17.10.2001

  2. Slide 2: Disclaimer

    Disclaimer This presentation contains certain statements that are neither reported financial results nor other historical information. These statements are forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ ma

  3. Slide 3: Content overview

    Nine months 2001: Conference call Content overview Sales key figures Debt structure USA sales and transaction/translation impact Outlook Conference Conferencecall call 17.10.2001 –3–

  4. Slide 4: Sales key figures

    Nine months 2001: Conference call Sales key figures Debt structure USA sales and transaction/translation impact Outlook Conferencecall Conference call 17.10.2001 –4–

  5. Slide 5: Stable sales in local currency

    Sales key figures Stable sales in local currency – 9 months* – – Change % – 2000 2001 CHF LW Textile, Leather & Paper Chemicals 1 947 1 830 -6 -1 Pigments & Additives 1 618 1 465 -10 -6 Masterbatches 879 812 -8 -4 Functional Chemicals 1 424 1 419 0 4 Life Science & Electronic Chemicals 1 186 1 211 2

  6. Slide 6: Divisional sales development 3rd quarter 2001 (1)

    Sales key figures Divisional sales development 3rd quarter 2001 (1) Textile, Leather & Paper Chemicals l Reduced consumer confidence mainly in the US put pressure on the textile segment l Fashion development towards black and fade colors remains unfavorable l Further positive impact from BTP leather

  7. Slide 7: Divisional sales development 3rd quarter 2001 (2)

    Sales key figures Divisional sales development 3rd quarter 2001 (2) Masterbatches l Asia and Europe saw some slowdown l Durable goods consumption slowdown l US decline almost stabilized Functional Chemicals l Detergents market weak l Pay-off of niche business strategy even in weak macroeconomic envi

  8. Slide 8: Divisional sales development 3rd quarter 2001 (3)

    Sales key figures Divisional sales development 3rd quarter 2001 (3) Life Science & Electronic Chemicals l Further flat screen volume increase off-set by depressed semiconductor cycle l LSM sales delays continued; customer industry consolidation prevents quick upswing l First big contract received fo

  9. Slide 9: Debt structure

    Nine months 2001: Conference call Sales key figures Debt structure USA sales and transaction/translation impact Outlook Conference call 17.10.2001 –9–

  10. Slide 10: Stable debt structure

    Debt structure Stable debt structure l Open long-term credit lines of CHF 900 million l Covenants are being met l High portion of fixed interest rates reduces dependency on changing interest rates l Solid debt maturity profile with nearly no short term maturity Conference call 17.10.2001 – 10 –

  11. Slide 11: Debt maturity profile

    Debt structure Debt maturity profile Additional flexibility Financial debt (in million CHF)* 1400 l Financing on a long term basis 1200 l First maturity in Cash 2003 1000 l No additional 800 financing Commited open lines required 600 400 * as of June 2001 200 0 2001 2002 2003 2004 2005 2006 2007 200

  12. Slide 12: Debt structure outlook (1)

    Debt structure Debt structure outlook (1) Short term outlook l 2001 CAPEX budget reduced by CHF 100 million l Net current assets will be further reduced l Asset disposal program will yield gross proceeds of ~ CHF 1 bn and a streamlined portfolio l Restructuring program will lower cost base by CHF 30

  13. Slide 13: Debt structure outlook (2)

    Debt structure Debt structure outlook (2) Medium term outlook l Interest coverage EBITA by 2004: 5–6 x l Gearing 100–150% by 2004 Conference call 17.10.2001 – 13 –

  14. Slide 14: USA sales and transaction/translation impact

    Nine months 2001: Conference call Sales key figures Debt structure USA sales and transaction/translation impact Outlook Conference call 17.10.2001 – 14 –

  15. Slide 15: Earnings and sales impact of a USD value shift

    USA sales and transaction/translation impact Earnings and sales impact of a USD value shift l Sales in the USA will be around 16% at year-end 2001 l Sales impact of a 10% USD value shift is 2.5%–3% l Operating income impact of a 10% USD value shift is approximately 6% Conference call 17.10.2001 – 15

  16. Slide 16: Reduced FX translation and transaction exposures (1)

    USA sales and transaction/translation impact Reduced FX translation and transaction exposures (1) Transaction risk policy l Selective hedging of main FX transaction risk positions – representing 80% – with options or forward contract depending on market conditions l FX move on main transaction expos

  17. Slide 17: Reduced FX translation and transaction exposures (2)

    USA sales and transaction/translation impact Reduced FX translation and transaction exposures (2) Translation* risk policy l Approximately 60% of the gross translation exposure is hedged on a selective basis n Compensated by same currency financing (natural hedge) n Selectively hedged by cross curre

  18. Slide 18: Outlook

    Nine months 2001: Conference call Sales key figures Debt structure USA sales and transaction/translation impact Outlook Conference call 17.10.2001 – 18 –

  19. Slide 19: Earnings to improve in 2002 (1)

    Outlook Earnings to improve in 2002 (1) 2001 impact of difficult economic environment l Initial effects of restructuring l Divestitures are on track l US and EU downturn impact l Operating margin for full year 2001 below margin of first half year 2001 l Ongoing R&D efforts to secure innovations Conf

  20. Slide 20: Earnings to improve in 2002 (2)

    Outlook Earnings to improve in 2002 (2) 2002 earnings to improve l Specialty and semi-specialty earnings will improve in 2002 due to replenishment of customer inventories l Several new product launches will result in above average growth in markets such as Agro Chemicals and Pigments l Restructuring

  21. Slide 21: Nine months 2001: Conference call

    Nine months 2001: Conference call Dr. Reinhard Handte, Chief Executive Officer François Note, Chief Financial Officer 17.10.2001

  22. Slide 22: Investor Relations Contacts

    Contacts Investor Relations Contacts Iris M. Welten Clariant International Ltd Building 907 Phone: +41 61 469 67 47 Rothausstrasse 61 Fax: +41 61 469 67 67 P.O. Box Mobile: +41 79 292 62 70 4132 Muttenz 1 e.mail: Iris.Welten@clariant.com Switzerland Philipp Hammel Phone: +41 61 469 67 40 Fax: +41 61

Clariant — 9M 2001 Earnings Presentation on 6ix